Queensland University leads international team researching ancient Australian plant to help in production of COVID-19 vaccine
On Apr. 7, 2020, the Queensland University of Technology (QUT) announced that it is leading an international team…
-
-
GSK and Vir Biotechnology entered collaboration to find coronavirus solutions
On Apr. 6, 2020, GSK and Vir Biotechnology announced a binding agreement to enter into a collaboration to…
-
XBiotech and BioBridge Global collaborate on FDA program to develop potential COVID-19 antibody-based treatment
On Apr. 3, 2020, XBiotech and BioBridge Global announced a collaboration to participate in a FDA investigational program…
-
Fred Hutch team launched hunt for coronavirus antibodies
On Apr. 2, 2020, a team of scientists at Fred Hutchinson Cancer Research Center in Seattle began searching…
-
Adaptive Biotechnologies and Amgen announced collaboration to address COVID-19 pandemic
On Apr. 2, 2020, Amgen and Adaptive Biotechnologies announced a collaboration aimed at helping address the COVID-19 pandemic….
-
Paratek Pharma announced BARDA funding for onshoring the manufacturing supply for NUZYRA (omadacycline)
On Apr. 1, 2020, Innovation Pharma announced BARDA had initiated funding to support the onshoring of Paratek manufacturing…
-
Henry Schein named exclusive distributor of second point-of-care antibody rapid test
On Apr. 1, 2020, Henry Schein announced that it will serve as the exclusive distributor in the U.S….
-
Luminex received BARDA contract to support development of second, rapid SARS-CoV-2 test
On Mar. 31, 2020, Luminex announced it had received $642,450 in funding from the Biomedical Advanced Research and…
-
BD, BioMedomics announced launch of rapid serology test to detect exposure to COVID-19
On Mar. 31, 2020, BD (Becton, Dickinson and Company) and BioMedomics announced the release of a new point-of-care…
-
Chembio announced launch of DPP COVID-19 serological point-of-care test
On Mar. 31, 2020, Chembio Diagnostics announced the U.S. launch of the rapid DPP COVID-19 serological point-of-care test…
-
Cerus formed group to research optimal production of COVID-19 convalescent plasma
On Mar. 26, 2020, Cerus announced it had formed a collaborative research group with the aim of optimizing…
-
Xencor and Vir Biotech announced license agreement for use of Xtend XmAb antibody technology to treat COVID-19
On Mar. 25, 2020, Xencor announced a technology license agreement with Vir Biotech in which Vir will have…
-
aTyr Pharma and its Hong Kong Subsidiary, Pangu BioPharma, announced government grant to fund bispecific antibody development platform
On Mar. 24, 2020, aTyr Pharma announced announced that the companyﾒs Hong Kong subsidiary, Pangu BioPharma, together with…
-
Sorrento and SmartPharm Therapeutics announced research and development collaboration develop a next-generation, gene-encoded antibody vaccine for COVID-19
On Mar. 23, 2020, Sorrento and SmartPharm Therapeutics announced a research and development collaboration to develop a next-generation,…
-
CSL Group to help battle Coronavirus
On Mar. 23, 2020, CSL announced that it was exploring development of a hyperimmune serum that could be…
-
Monkeys developed protective antibodies to SARS-CoV-2
On Mar. 17, 2020, a small study of macaques found they don’t develop a coronavirus infection the second…
-
Regeneron announced important advances in novel COVID-19 antibody program
On Mar. 17, 2020, Regeneron announced that its scientists had isolated hundreds of virus-neutralizing, fully human antibodies from…
-
Vir Biotec announced intent to collaborate with Biogen on manufacturing of antibodies to potentially treat COVID-19
On Mar. 12, 2020, Vir Biotech announced it had signed a letter of intent with Biogen for the…
-
AbCellera and Eli Lilly to co-develop antibody therapies for treatment of COVID-19
On Mar. 12, 2020, AbCellera and Eli Lilly announced an agreement to co-develop antibody products for the treatment…
-
Vir Biotec announced research collaboration with NIH Vaccine Research Center on antibodies against coronaviruses
On Mar. 11, 2020, Vir Biotech announced a research collaboration agreement with the NIH to advance characterization and…
-
Emergent BioSolutions initiated development of product candidates for treatment of Coronavirus
On Mar. 11, 2020, Emergent BioSolutions announced it has initiated development of two product candidates for treatment and…
-
Biotechnology | HIV | NIH | Therapeutics
Drug-delivery technology leads to sustained HIV antibody production in NIH study
On Mar. 9, 2020, researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the…
-
Mount Sinai and Harbour BioMed collaborated to advance treatment of cancer and Coronavirus COVID-19
On Mar. 6, 2020, Mount Sinai Health System and Harbour BioMed (HBM) announced a multi-year, multifaceted collaboration to…
-
Vir Biotec and WuXi Biologics announced collaboration for global development of antibodies to treat COVID-19
On Feb. 25, 2020, Vir Biotech and WuXi Biologics announced a development and manufacturing collaboration to advance and…
-
Artificial intelligence yielded new antibiotic
On Feb. 20, 2020, using a machine-learning algorithm, researchers at MIT and the Broad Institute of MIT and…
-
Vir Biotec identified two antibodies that bind to spike protein of SARS-CoV-2
On Feb. 12, 2020, Vir Biotech announced it had identified two monoclonal antibodies (mAbs) that bind to SARS-CoV-2…
-
AbCellera mobilized response to the novel coronavirus outbreak as part of its DARPA P3 program
On Jan. 28, 2020, AbCellera confirmed that it had mobilized its pandemic response platform against the ongoing outbreak…
-
Vir Biotec applying multiple platforms to address public health risk from coronavirus
On Jan. 22, 2020, Vir Biotech announced it was working to rapidly determine whether its previously identified anti-coronavirus…
-
Lack of new antibiotics threatens global efforts to contain drug-resistant infections
On Jan. 17, 2020, the World Health Organization (WHO) reported that declining private investment and lack of innovation…
-
Researchers at Vanderbilt University Medical Center isolated an antibody that blocks bird flu
On Dec. 12, 2019, Vanderbilt University Medical Center (VUMC) researchers James Crowe Jr., MD, and colleagues announced they…
